Litigation Funding Rights Protected In New Jersey
NJ Corporate Entity Seeks to Limit Funding The New Jersey Civil Justice Institute claims litigation funding unfairly sways plaintiffs’ settlement decisions by providing financial support.
NJ Corporate Entity Seeks to Limit Funding The New Jersey Civil Justice Institute claims litigation funding unfairly sways plaintiffs’ settlement decisions by providing financial support.
The Impact of Wrongful Convictions: How USClaims can help. Freedom: it’s a right we often take for granted. But for the wrongfully convicted, it’s snatched
DELRAY BEACH, Fla., October 22, 2021 — USClaims (USClaims.com), the longest continuously operating pre-settlement funding firm in the U.S., today announced its $77.5MM 144A litigation finance
Prior to the pandemic, it might have been difficult to imagine a legal team conducting all of their jury research online – and that their
The legal profession, with its long hours, late nights, and high tension, can quickly lead to burnout among attorneys. If lawyers ignore the signs of
An insurance company is in the business of making money. When someone is injured and files a claim, they are expecting fair compensation. But
DELRAY BEACH, Fla., Aug. 5, 2020 /PRNewswire/ — US Claims, the longest continuously operating pre-settlement funding company in the U.S., today announced several new executive appointments: Steve Bashmakov –
Even small doses of PFAS have been linked to various forms of cancer, reproductive damage, and immune system harm—to name just a few.
Volatile NDMA has been shown to potentially induce tumors of the lung, bladder, kidney, liver, pancreas, esophagus, and tongue.
By contacting and submitting my information to USClaims, I consent and agree to the Privacy Policy and Terms of Use, and certify that I am not a resident of the European Union/UK. Do not Sell or Share My Personal Information (CA Residents Only)
©2024 US Claims Opco LLC. USClaims and the circular logo are trademarks of US Claims Opco LLC.
US Claims Capital, LLC NMLS #2530828 | USClaims Connecticut LLC NMLS#2513033
Currently, USClaims does not conduct business with residents of the European Union/UK. If you are a resident of the European Union, DO NOT USE THIS SITE. USClaims does not currently provide funding to consumers residing in Arkansas, Kentucky, Maryland, Montana, Washington D.C., or West Virginia. Additional restrictions may apply.
If you reside in South Carolina, PLEASE CLICK HERE.
If you reside in Illinois, PLEASE CLICK HERE.
If you reside in Missouri, PLEASE CLICK HERE.
California residents covered by the California Consumer Privacy Act have the right to opt-out from the “sale” or “sharing” of their personal information via browser-enabled opt-out preference signals. USC does not “sell” or “share” personal information of California residents. However, we will honor your opt-out preference signals as valid requests to opt-out of sale/sharing for the browser.
DO NOT SELL OR SHARE MY PERSONAL INFORMATION (CA residents only)
For more information, please see our CCPA Notice.
*By clicking “Continue”, (1) I agree to be contacted by USClaims regarding its offers and services via the phone number provided above, including via autodialed calls and texts, and (2) I agree to the Terms of Use and Privacy Policy, including mandatory arbitration. I understand my consent is not a condition to obtain services or advances.
*By clicking “Continue”, (1) I agree to be contacted by USClaims regarding its offers and services via the phone number provided above, including via autodialed calls and texts, and (2) I agree to the Terms of Use and Privacy Policy, including mandatory arbitration. I understand my consent is not a condition to obtain services or advances.
*By clicking “Submit”, (1) I agree to be contacted by USClaims regarding its offers and services via the phone number provided above, including via autodialed calls and texts, and (2) I agree to the Terms of Use and Privacy Policy, including mandatory arbitration. I understand my consent is not a condition to obtain services or advances.